Flash Finance

Fortis Healthcare LimitedFORTISCorporate

Healthcare Medical Care Facilities Latest results: Mar 2026 14 quarters of data
Consolidated Standalone
₹736.50
MCap ₹55,603 Cr · P/E 52.3
Fortis Healthcare Limited — Stock analysis & AI research Fortis Healthcare Limited — Multibagger AI analysis Fortis Healthcare Limited — Seasonality — best & worst months Fortis Healthcare Limited — Technical indicators & charts Fortis Healthcare Limited — Technical setup — score, trend, support & resistance Fortis Healthcare Limited — Live exchange announcements
📋 High Profit Growth Stocks📋 Stocks With Strong Quarterly Results📋 Mid Cap Stocks List 📈 RSI Oversold Stocks📈 New 52-Week Low Stocks📈 20-Day Breakdown Stocks📈 Lowest Technical Score📈 Multi-Timeframe Bearish Stocks📈 Stocks Near 52-Week Low 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹2,365 Cr
Sales · Mar 2026
+17.8% YoY
₹532 Cr
Operating Profit · Mar 2026
+22.2% YoY
22.5%
OPM % · Mar 2026
+3.7% YoY
₹271 Cr
Net Profit · Mar 2026
+44.1% YoY
₹3.52
EPS · Mar 2026
+44.3% YoY

📝 Fortis Healthcare Limited — results explained

Quarter ended March 2026 (Q4 FY26)

Fortis Healthcare Limited reported revenue of ₹2,365 crore for the quarter ended March 2026 (Q4 FY26), up 17.8% from ₹2,007 crore in the same quarter last year, and up 4.4% sequentially over the December 2025 quarter.

Net profit rose 44.1% year-on-year to ₹271 crore, from ₹188 crore. Earnings per share (EPS) came in at ₹3.52.

Operating profit stood at ₹532 crore — an operating margin (OPM) of 22.5%, compared with 21.7% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Fortis Healthcare Limited posted revenue of ₹9,128 crore, a growth of 17.3% over FY25, with a net profit of ₹1,064 crore (up 31.4% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹9,128 crore with a net profit of ₹1,064 crore.

Valuation snapshot

At the current price of ₹736.50, FORTIS has a market capitalisation of ₹55,603 crore and a trailing P/E of about 52.3.

Within the Medical Care Facilities industry, it is the 4th-largest of the 11 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 31.17%, foreign institutional investors (FIIs) 25.20%, domestic institutional investors (DIIs) 32.23%, public shareholders 11.40% of Fortis Healthcare Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹55,603 Cr
Current Price ?
₹736.5
P/E ?
52.27below ind
Industry P/E ?
56.40
P/B ?
5.62
P/S ?
6.09
P/FCF ?
82.62
Enterprise Value ?
₹59,076 Cr
EV/EBITDA ?
28.33
PEG ?
1.94
Earnings Yield ?
2.8%
Dividend Yield ?
0.13%
Profitability & Returns
Sales (TTM) ?
₹9,128 Cr
OPM ?
22.8%
Profit after tax (TTM) ?
₹1,064 Cr
EPS (TTM) ?
₹14.09
ROCE ?
13.0%
ROE ?
10.8%
ROA ?
6.7%
Growth
Sales — latest qtr ?
₹2,365 Cr
PAT — latest qtr ?
₹271 Cr
YoY qtr sales growth ?
17.8%
YoY qtr profit growth ?
44.1%
Sales growth (3y) ?
13%
Sales growth (5y) ?
18%
Profit growth (3y) ?
27%
Profit growth (5y) ?
64%
Financial Health
Debt ?
₹3,473 Cr
Debt to Equity ?
0.35
Interest Coverage ?
5.2
Current Ratio ?
N/A
Ownership
Promoter holding ?
31.17%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
-22.7%
Return 6 months ?
-17.3%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best
Metric Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026 YoY % QoQ %
Sales 1,5601,6431,6571,7701,6801,7861,8591,9881,9282,0072,1672,3312,2652,365 +17.8% +4.4%
Operating Profit 276271272330284381343435375435491556506532 +22.2% +5.1%
Other Income 1414815714131321243126-34-2 -108.2% +94.1%
Interest 3332313233353536456870758684 +24.3% -2.3%
Depreciation 838279848792919597102101106120122 +19.3% +1.7%
Profit Before Tax 186183171233183271230261279237351425266324 +37.0% +21.8%
Net Profit 142138124184134203174193254188267329197271 +44.1% +37.6%
EPS 1.721.761.482.301.782.372.202.343.282.443.454.262.573.52 +44.3% +37.0%
OPM % 17.7% 16.5% 16.4% 18.7% 16.9% 21.3% 18.4% 21.9% 19.5% 21.7% 22.7% 23.9% 22.3% 22.5% +3.7% +0.9%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹7,783 Cr ₹9,128 Cr ₹9,128 Cr +17.3%
Operating Profit ₹1,588 Cr ₹2,085 Cr ₹2,085 Cr +31.3%
OPM % 20.40% 22.84% 22.84% +12.0%
NPM % 10.40% 11.65% 11.65% +12.0%
Other Income ₹72 Cr ₹21 Cr ₹21 Cr -70.3%
Depreciation ₹386 Cr ₹449 Cr ₹449 Cr +16.4%
Interest ₹184 Cr ₹315 Cr ₹315 Cr +70.7%
EBIT ₹1,202 Cr ₹1,636 Cr ₹1,636 Cr +36.1%
PBT ₹1,007 Cr ₹1,366 Cr ₹1,366 Cr +35.7%
Tax ₹116 Cr ₹97 Cr ₹97 Cr -17.1%
Net Profit ₹809 Cr ₹1,064 Cr ₹1,064 Cr +31.4%
EPS ₹10.26 ₹13.80 ₹13.80 +34.5%
Material Cost ₹1,838 Cr ₹548 Cr ₹548 Cr -70.2%
Employee Cost ₹1,167 Cr ₹317 Cr ₹317 Cr -72.9%
Extraordinary Items ₹-85 Cr ₹24 Cr ₹24 Cr +127.6%

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 755755755755 +0.0%
Reserves 6,4876,9088,1629,141 +12.0%
Borrowings 9261,1552,4753,473 +40.3%
Other Liabilities 3,9214,1531,9852,598 +30.9%
Total Liabilities 12,08912,97113,37715,966 +19.4%
Fixed Assets 9,4269,87410,42412,232 +17.3%
CWIP 228542407432 +6.1%
Investments 210230169243 +43.8%
Other Assets 2,2252,3262,3783,059 +28.6%
Total Assets 12,08912,97113,37715,966 +19.4%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 8221,1001,4241,601 +12.4%
Cash from Investing Activity -372-889-780-1,538 -97.2%
Cash from Financing Activity -471-86-714164 +123.0%
Net Cash Flow -21125-70227 +424.3%
Free Cash Flow 367172591673 +13.9%
CFO/OP 100%104%97%90% -7.2%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 34333742 +13.5%
Inventory Days 31242324 +4.3%
Days Payable 179164161165 +2.5%
Cash Conversion Cycle -115-107-101-99 +2.0%
Working Capital Days -22-124-30-34 -13.3%
ROCE % 10%10%12%13% +8.3%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 31.17%31.17%31.17%31.17%31.17% +0.0%
FIIs 27.18%27.90%27.84%25.98%25.20% -3.0%
DIIs 29.79%29.14%29.33%31.35%32.23% +2.8%
Public 11.87%11.79%11.65%11.50%11.40% -0.9%
No. of Shareholders 2,05,3732,20,7662,33,1562,26,6852,20,743 -2.6%

⚖️ Peer comparison

Industry: Medical Care Facilities · 11 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 APOLLOHOSP Apollo Hospitals ₹7,988.50 114,862 59.2 25,229 2,002 14.9% 7.9% 15.8% 33.1% 18.1% 32.9%
2 MAXHEALTH Max Healthcare ₹1,037.70 101,000 69.2 8,712 1,457 26.6% 16.7% 19.1% 34.1% 16.7% 4.9%
3 MANIPALHOS Manipal Health ₹710.85 93,504 — — — — — — — 28.2% -8.3%
4 FORTIS Fortis Healthcare ₹887.80 67,025 64.3 9,128 1,064 22.8% 11.7% 17.3% 31.4% 17.8% 44.1%
5 ASTERDM Aster DM ₹763.50 66,552 198.5 4,876 363 19.0% 7.5% 44.2% 138.8% 21.6% -68.9%
6 MEDANTA Global Health ₹1,445.60 38,846 69.8 4,683 553 20.9% 11.8% 19.4% 15.1% 26.5% -1.1%
7 NH Narayana Hrudayalaya ₹1,869.90 37,978 46.6 9,073 817 19.3% 9.0% 41.4% 1.9% 78.0% 5.4%
8 KIMS Krishna Institute ₹767.50 30,711 148.9 4,214 194 19.8% 4.6% 28.7% -41.5% 35.3% -56.0%
9 RAINBOW Rainbow Children's ₹1,450.00 14,710 51.6 1,820 290 31.6% 15.9% 12.4% 15.2% 33.2% 16.2%
10 GAUDIUMIVF Gaudium IVF ₹116.42 847 36.4 106 23 32.9% 21.8% — — 9.1% -42.2%
11 MOMSBELIEF Rays of Belief ₹223.00 466 — — — — — — — 136.4% 616.1%
❓ Frequently asked questions
What was Fortis Healthcare Limited's revenue in Q4 FY26?
Fortis Healthcare Limited reported revenue of ₹2,365 crore for the quarter ended March 2026 (Q4 FY26), up 17.8% from ₹2,007 crore in the same quarter last year, and up 4.4% sequentially over the December 2025 quarter.
What was Fortis Healthcare Limited's net profit in Q4 FY26?
Net profit rose 44.1% year-on-year to ₹271 crore, from ₹188 crore. Earnings per share (EPS) came in at ₹3.52.
What is FORTIS's market capitalisation and P/E ratio?
At the current price of ₹736.50, FORTIS has a market capitalisation of ₹55,603 crore and a trailing P/E of about 52.3.
Who owns Fortis Healthcare Limited? (shareholding pattern)
As of Jun 2026, promoters held 31.17%, foreign institutional investors (FIIs) 25.20%, domestic institutional investors (DIIs) 32.23%, public shareholders 11.40% of Fortis Healthcare Limited.
TTM ends 2026-03-31. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI